Pharma sector: Firms to clock 11% sales, EBITDA growth in Q1FY26

India's pharmaceutical sector is projected to experience an 11% year-on-year growth in sales and EBITDA for Q1 FY26, driven by strong market performance across various regions. The hospital segment is expected to lead with a 17% growth, while diagnostics firms anticipate a 14% sales increase. Government initiatives and investments in R&D further support the industry's optimistic outlook.

from Latest Business News Today: Stock Markets, Financial News, India Business & World Business News https://ift.tt/wY9GSnL
https://ift.tt/ZMkewTb